A Gem In Cephalon’s Pipeline? Cinquil Offers The Promise Of A Boost (The Pink Sheet)
This is copyright protected information, to receive the full article, please click here to sign up and register.
Bayer to up R&D spend as Higgins looks to the future (PharmaTimes.com)
Pfizer critical of “selective outcome reporting” study (PharmaTimes.com)
Biota buys UK’s Prolysis and assets from USA’s MaxThera (PharmaTimes.com)
ACAAI: Asthma May Vary with Weight (MedPage Today)
ACAAI: Soon, Heat to Treat Asthma (MedPage Today)
How The Body Prevents Formation Of Blood Vessels Has Implications For Cancer Treatment (Medical News Today)
Health Reform Has Fiscal, Political Burdens For States (Medical News Today)
SUBSCRIBE